Amino Acids for Cardiac Surgery Associated AKI
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT07001098
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Acute Kidney Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Day - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Amino Acids — DRUGThe participants receive a continuous infusion of a balanced mixture of amino acids (Trophamine) in a dose of 2g/kg/day (max 100g/day) starting at the time of cardiac surgery up to 3 days
- Placebo — DRUGThe participants receive a continuous infusion of a lactated ringers (placebo), equivalent volume to amino acids, starting at the time of cardiac surgery up to 3 days
Study Details
The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.
Key Dates
- Start date
- Sep 30, 2025
- Status verified
- May 2025
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Amino acidParticipants receive amino acids for up to 3 days starting at the time of their cardiac surgery
- Placebo Comparator: PlaceboParticipants receive equivalent volume of placebo for up to 3 days starting at the time of their cardiac surgery
Primary Outcome Measure
Number of Participants with Amino acids Related Adverse Events [ Time Frame: Baseline, Daily during infusion upto 48 hours after completion of infusion (upto 5 days) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Lucile Packard Children's Hospital | Palo Alto | California | 94305 | - |
Find similar trials in Palo Alto, CA
By research site
Related Studies
- Angiotensin 2 for AKI After OLTPHASE4 · Enrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn RegistryRecruiting · Potrero Medical · Los Angeles, California
- KIDney Injury in Times of COVID-19 (KIDCOV)Recruiting · University of California, San Francisco · San Francisco, California
- NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury TrialPHASE2 · Recruiting · Kaiser Permanente · San Francisco, California